Depression. This block contains disorders in which the fundamental disturbance is a change in affect or mood to depression (with or without associated anxiety) or to elation. The mood change is usually accompanied by a change in the overall level of activity
Conditions
Interventions
Intervention 1: Intervention group: consists of 23 depressed people who receive two tablets of magnesium oxid tablets daily after breakfast and one after dinner for 8 weeks, and after 8 weeks again, B
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: People aged between 20-60 years old and whose depression is diagnosed by the relevant psychiatrist
Exclusion criteria
Exclusion criteria: Schizophrenia Bipolar disorder kidney disease Myasthenia Graves Gastrointestinal disease Surgery scheduled in the next three months Use of a drug that interferes with magnesium Acute heart failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression Score in Beck Questionnaire. Timepoint: Before the intervention and two months after the intervention. Method of measurement: Beck Depression Inventory. | — |
Secondary
| Measure | Time frame |
|---|---|
| BDNF. Timepoint: Before the intervention and two months after the intervention. Method of measurement: Measuring with laboratory kit on blood sample.;Serum magnesium. Timepoint: Before the intervention and two months after the intervention. Method of measurement: Serum magnesium test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Afsharfar
Zahedan University of Medical Sciences
Outcome results
None listed